GAMMA Investing’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CA
VCM
MPWT
FFA
TFA
EB
GWM
DCM
GAMMA Investing's TNDM Position: Q3 2026 in Review
GAMMA Investing reduced its Tandem Diabetes Care (TNDM) stake by 2.4% in Q3 2026, selling an estimated $732 and leaving 1,605 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.
GAMMA Investing first reported a position in TNDM in Q4 2023 and has held it in 12 quarters since. The position peaked at $212K in Q3 2024. 9 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.
- GAMMA Investing held 1,605 shares of Tandem Diabetes Care worth $26.2K as of Q3 2026.
- GAMMA Investing sold 39 Tandem Diabetes Care shares in Q3 2026, an estimated $732.
- Tandem Diabetes Care made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2776 holding.
- GAMMA Investing first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 12 quarters since.
- GAMMA Investing's Tandem Diabetes Care position peaked at $212K in Q3 2024.
- 9 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.